Bayer bags rights to haemophilia A gene therapy
written on 23.06.2014
Bayer bags rights to haemophilia A gene therapy
Latest Reports
New Era in Access to Rare Disease Drugs in Canada
Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first…
“Canada Needs to do Better in Supporting Innovative Biopharma”
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in…
Success in Rare Disease Patient Advocacy — What it Takes
After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica Weldon founded Bridge the…